sofosbuvir

Details

Files

Generic Name:

sofosbuvir

Project Status:

Complete

Therapeutic Area:

Hepatitis C, chronic

Manufacturer:

Gilead Sciences Canada Inc.

Call for patient/clinician input open:

January 6, 2016

Brand Name:

Sovaldi

Project Line:

Reimbursement Review

Project Number:

SF0464-000

Call for patient/clinician input closed:

February 25, 2016

NOC Status at Filing:

Post NOC

Submission Type:

Request For Advice

Indications:

Hepatitis C, chronic

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

May 18, 2016

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Request for Advice View PDF

Patient Group Input Submissions View PDF

Last Updated : January 6, 2016